[{"indications": "Indications\u00a0\n(From Carbamazepine and related antiepileptics: British National Formulary)\nCarbamazepine and related antiepileptics", "name": "ESLICARBAZEPINE ACETATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.8 Antiepileptic drugs", "4.8.1 Control of the epilepsies", "Carbamazepine and related antiepileptics"], "cautions": "Cautions\u00a0avoid abrupt withdrawal; hyponatraemia (monitor plasma-sodium\r\nconcentration in patients at risk and discontinue treatment if hyponatraemia occurs); PR-interval prolongation (avoid concomitant\r\nadministration of drugs that prolong PR interval); elderly; interactions: see Interactions in section\r\n4.8.1 and Appendix 1 (eslicarbazepine)", "side-effects": "Side-effects\u00a0gastro-intestinal disturbances; dizziness, drowsiness,\r\nheadache, impaired coordination, tremor, visual disturbances, fatigue;\r\nrash; less commonly dry mouth, dehydration, gingival\r\nhyperplasia, stomatitis; palpitation, bradycardia, hypertension, hypotension,\r\nepistaxis, appetite changes, weight changes, agitation, hyperactivity,\r\nconfusion, mood changes, psychosis, impaired memory, insomnia, dysaesthesia,\r\ndystonia, parosmia, movement disorders, convulsions, peripheral neuropathy,\r\nnystagmus, dysarthria, taste disturbance, liver disorders, hypothyroidism,\r\nanaemia, hyponatraemia (see Cautions), electrolyte imbalance, tinnitus,\r\nalopecia, sweating, nail disorder, myalgia, nocturia, menstruation\r\nchanges, malaise, chills, peripheral oedema; very rarely pancreatitis, thrombocytopenia, and leucopenia; PR-interval prolongation\r\nalso reported; suicidal ideation", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/203911.htm", "doses": ["adult over 18 years, initially\r\n400\u00a0mg once daily, increased after 1\u20132 weeks to 800\u00a0mg once daily;\r\nmax. 1.2\u00a0g"], "pregnancy": "Pregnancy\u00a0see Pregnancy"}]